Advertisement
Canada markets close in 2 hours 16 minutes

  • S&P/TSX

    21,877.96
    +4.24 (+0.02%)
     

  • S&P 500

    5,042.83
    -28.80 (-0.57%)
     

  • DOW

    38,100.27
    -360.65 (-0.94%)
     

  • CAD/USD

    0.7318
    +0.0020 (+0.28%)
     

  • CRUDE OIL

    82.90
    +0.09 (+0.11%)
     

  • Bitcoin CAD

    88,237.35
    -644.77 (-0.73%)
     

  • CMC Crypto 200

    1,392.65
    +10.08 (+0.73%)
     

  • GOLD FUTURES

    2,343.10
    +4.70 (+0.20%)
     

  • RUSSELL 2000

    1,972.17
    -23.26 (-1.17%)
     

  • 10-Yr Bond

    4.7040
    +0.0520 (+1.12%)
     

  • NASDAQ

    15,576.04
    -136.71 (-0.87%)
     

  • VOLATILITY

    16.42
    +0.45 (+2.82%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6812
    -0.0007 (-0.10%)
     
MARKETS LIVE BLOG:

STOCKS SLIDE AFTER META'S REALITY CHECK, DOWNBEAT GDP

Caterpillar sinks 7% after earnings, management sees weakness in Europe, Asia-Pacific

Actelion shares fall on report it rejects J&J offer

Reuters
A general view shows Swiss biotech group Actelion Headquarters in Allschwil near Basel February 17, 2015. REUTERS/Arnd Wiegmann (Reuters)

ZURICH (Reuters) - Shares in Swiss biotech company Actelion fell more than 6 percent after news outlet streetinsider.com reported on Wednesday the company had rejected a full takeover offer by U.S. healthcare group Johnson & Johnson and may sell a unit. Actelion declined to comment on the report, which cited an unidentified source, and referred to a statement the company had published on Friday. The companies had confirmed last week they were in talks about a possible transaction. (Reporting by Paul Arnold, Editing by Michael Shields)